Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Galapagos NV

GLPG
23,76
-0,14 (-0,59%)
18 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/1/202514:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202512:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202507:30GLOBEGalapagos to Unlock Shareholder Value by Declaring its..
07/1/202522:01GLOBEGalapagos to Present at the 43rd Annual J.P. Morgan..
09/12/202413:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/12/202418:30GLOBEGalapagos Announces Encouraging New Results from Ongoing..
20/11/202422:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/11/202422:01GLOBEGalapagos to Present Results of Pioneering Innovation in..
30/10/202421:01GLOBEGalapagos Reports Third Quarter 2024 Financial Results and..
08/10/202422:35EDGAR2Form SC 13D/A - General Statement of Acquisition of..
07/10/202412:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/10/202407:00GLOBEGalapagos welcomes Oleg Nodelman to its Board of Directors..
30/9/202422:01GLOBEGalapagos receives transparency notification from EcoR1..
16/9/202422:01GLOBEGalapagos receives transparency notification from EcoR1..
03/9/202422:01GLOBEGalapagos receives transparency notification from FMR LLC
23/8/202422:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/8/202422:01EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
23/8/202407:00GLOBEGalapagos announces FDA clearance of IND application for..
21/8/202422:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/8/202422:01GLOBEGalapagos receives transparency notification from FMR LLC
01/8/202422:01PRNUSBridGene Biosciences Expands Strategic Collaboration with..
14/6/202422:01GLOBEGalapagos presents encouraging new data for CD19 CAR-T..
30/5/202422:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/5/202422:01GLOBEGalapagos and Adaptimmune sign clinical collaboration..
16/5/202422:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/5/202422:01GLOBEGalapagos creates new subscription right plans
16/5/202414:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/5/202422:01GLOBEGalapagos and Blood Centers of America announce strategic..
02/5/202422:01GLOBEGalapagos reports first quarter 2024 financial results  
30/4/202422:01GLOBEGalapagos’ shareholders adopt all resolutions proposed by..
04/4/202422:01GLOBEGalapagos showcases innovative approach in hematological..
28/3/202421:01GLOBEGalapagos publishes 2023 annual report and announces Annual..
26/3/202421:01GLOBEGalapagos appoints Andrew Dickinson as Non-Executive..
23/2/202412:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/2/202422:01GLOBEFrontier Medicines Announces Oversubscribed $80 Million..
16/2/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202422:01GLOBEGalapagos presents at EBMT-EHA annual meeting 2024
14/2/202423:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202422:01GLOBEGalapagos completes transaction to transfer Jyseleca®..
Apertura: 23,97 Min: 23,70 Max: 24,04
Chiusura: 23,90

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network